Publications


2021

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.

Eriksson M, Eklund M, Borgquist S, Hellgren R, Margolin S, Thoren L, Rosendahl A, Lång K, Tapia J, Bäcklund M, Discacciati A, Crippa A, Gabrielson M

...
J Clin Oncol.
202103
https://pubmed.ncbi.nlm.nih.gov/33734864

Breast Cancer Risk Genes – Association Analysis in More than 113,000 Women.

Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C,

...
N Engl J Med.
202101
https://pubmed.ncbi.nlm.nih.gov/33471991

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women.

Eriksson M, Czene K, Conant EF, Hall P. Cancers (Basel). 2021 Jan 15;13(2):E302. doi: 10.3390/cancers13020302. PMID: 33467653

...
Cancers (Basel).
202101
https://pubmed.ncbi.nlm.nih.gov/33467653

2020

Sense of coherence and risk of breast cancer.

Hu K, Eriksson M, Wengström Y, Czene K, Hall P, Fang F. Elife. 2020 Nov 23;9:e61469. doi: 10.7554/eLife.61469. PMID: 33226344

...
Elife.
202011
https://pubmed.ncbi.nlm.nih.gov/33226344

Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population-based cohort study.

Tan PS, Ali MA, Eriksson M, Hall P, Humphreys K, Czene K.
Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33309.

...
Int J Cancer.
202009
https://pubmed.ncbi.nlm.nih.gov/32976625

Predictors of mammographic microcalcifications.

Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, Hall P. Int J Cancer. 2020 Sep 19. doi: 10.1002/ijc.33302.

 

...
Int J Cancer.
202009
https://pubmed.ncbi.nlm.nih.gov/32949149

Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.

Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, Förnvik D, Sartor H, Mavaddat N, Easton D, Hall P. Radiology. 2020 Sep 8:201620. do

...
Radiology.
202009
https://pubmed.ncbi.nlm.nih.gov/32897160

Association between breast cancer risk and disease aggressiveness: characterizing underlying gene expression patterns.

Ugalde-Morales E, Grassmann F, Humphreys K, Li J, Eriksson M, Tobin NP, Borg Å, Vallon-Christersson J, Hall P, Czene K. Int J Cancer. 2020 Aug 28. do

...
Int J Cancer.
202008
https://pubmed.ncbi.nlm.nih.gov/32856720

Hormonal determinants of mammographic density and density change.

Gabrielson M, Azam S, Hardell E, Holm M, Ubhayasekera KA, Eriksson M, Bäcklund M, Bergquist J, Czene K, Hall P. Breast Cancer Res. 2020 Aug 26;22(1):

...
Breast Cancer Res.
202008
https://pubmed.ncbi.nlm.nih.gov/32847607

Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.

Yang H, Holowko N, Grassmann F, Eriksson M, Hall P, Czene K. BMC Med. 2020 Aug 25;18(1):225. doi: 10.1186/s12916-020-01690-y.PMID: 32838791

...
BMC Med.
202008

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R

...
Nat Rev Clin Oncol.
202006
https://pubmed.ncbi.nlm.nih.gov/32555420

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O’Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki

...
Nat Genet.
202005
https://pubmed.ncbi.nlm.nih.gov/32424353

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q, Jung A, Abu-Ful Z, Ahearn T, Andru

...
J Natl Cancer Inst.
202005
https://pubmed.ncbi.nlm.nih.gov/32359158

Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.

Holowko N, Eriksson M, Kuja-Halkola R, Azam S, He W, Hall P, Czene K. Cancer Res. 2020 Apr 1;80(7):1590-1600. doi: 10.1158/0008-5472.CAN-19-2455. PMI

...
Cancer Res.
202004
https://pubmed.ncbi.nlm.nih.gov/32241951

Mammographic Density Change and Risk of Breast Cancer.

Azam S, Eriksson M, Sjölander A, Hellgren R, Gabrielson M, Czene K, Hall P. J Natl Cancer Inst. 2020 Apr 1;112(4):391-399. doi: 10.1093/jnci/djz149.

...
J Natl Cancer Inst.
202004
https://pubmed.ncbi.nlm.nih.gov/31298705

European women’s perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.

Rainey L, van der Waal D, Jervaeus A, Donnelly LS, Evans DG, Hammarström M, Hall P, Wengström Y, Broeders MJM. BMC Cancer. 2020 Mar 24;20(1):247. do

...
BMC Cancer.
202003
https://pubmed.ncbi.nlm.nih.gov/32209062

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermis

...
Nat Commun.
202001
https://pubmed.ncbi.nlm.nih.gov/31949161

Inclusion of endogenous plasma dehydroepiandrosterone sulphate and mammographic density in risk prediction models for breast cancer.

Gabrielson M, Ubhayaseker KA, Acharya SR, Andersson Franko M, Eriksson M, Bergquist J, Czene K,Hall P. Cancer Epidemiol Biomarkers Prev. 2020 Jan 16.

...
Cancer Epidemiol Biomarkers Prev.
202001
https://pubmed.ncbi.nlm.nih.gov/31948996

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghouss

...
Nat Genet.
202001
https://pubmed.ncbi.nlm.nih.gov/31911677

2019

The impact of alcohol consumption and physical activity on breast cancer: the role of breast cancer risk.

Rainey L, Eriksson M, Trinh T, Czene K, Broeders MJM, van der Waal D, Hall P. Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32846. [Epub ahead of print

...
Int J Cancer.
201912
https://pubmed.ncbi.nlm.nih.gov/31863475